PDPN and colorectal carcinoma: Notably, treatment with F. rodentium and its metabolites significantly inhibited the frequency of PDPN+ CD8+ T cells in the spleen, MLNs, and tumors compared to that in the CRC control group (Fig. 4A), indicating that the protein PDPN levels correlate negatively with the cytotoxic capacity of CD8+ T cells.